🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of the study are to further evaluate the efficacy an...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2021-04-16
Trial ID
NCT04845399
Treatments Being Tested
The primary objectives of this study are: to evaluate the safety and tolera...
Status
Completed
Location
Research Site
Start Date
2010-11
Trial ID
NCT01181128
Treatments Being Tested
The study is designed as a randomized, two-armed, double-blind, single-dose...
Status
Completed
Location
Seyed-Al-Shohada Hospital
Start Date
2023-07-22
Trial ID
NCT06137092
Treatments Being Tested
Primary objective: To assess the pharmacokinetics of Recombinant Human Coag...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2019-03-08
Trial ID
NCT03747653
The indication for this product is to control and prophylaxis in patients w...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2026-06-12
Trial ID
NCT07684898
Treatments Being Tested
The primary objective of the study is to evaluate the long-term safety of r...
Status
Completed
Location
Research Site
Start Date
2011-12
Trial ID
NCT01454739
Treatments Being Tested
To evaluate the prophylactic efficacy of recombinant human coagulation fact...
Status
Recruiting
Location
Beijing tongren hospital,CMU
Start Date
2023-12-27
Trial ID
NCT06142552
Treatments Being Tested
The primary objectives of the study are to evaluate the efficacy of Recombi...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2020-10-15
Trial ID
NCT04456387
Primary objective: To assess the pharmacokinetics, Safety and immunogenicit...
Status
Completed
Location
People'S Hospital of Zhengzhou
Start Date
2022-04-14
Trial ID
NCT05265286
Treatments Being Tested
The indication for this product is to control bleeding in patients with hem...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2026-04-14
Trial ID
NCT07663903
Treatments Being Tested